文献速递免疫规划卫生政策与健康促进

HPV疫苗接种偏好:离散选择实验的系统综述

Parent, provider and vaccinee preferences for HPV vaccination: A systematic review of discrete choice experiments.
PubMed 文献 · Vaccine · 2020-10-03

该系统综述检索PubMed和Embase至2019年5月,纳入12项关于HPV疫苗接种的离散选择实验研究。结果显示结局属性最为突出,有效性 consistently 获得高相对重要性评分,接种年龄等过程因素也影响决策,高收入国家与中低收入国家在成本属性上差异最明显。作者指出中低收入国家证据缺乏令人担忧,政策制定需结合具体情境理解驱动接种决策的特征。

要点

  • 结局属性(尤其有效性)是HPV疫苗接种决策中最突出的偏好维度。
  • 接种年龄等过程因素对决策有重要影响,成本属性在高收入与中低收入国家间差异明显。
  • 中低收入国家(宫颈癌负担最高)的偏好证据缺乏,需优先开展当地研究。

核心结论

  • 本综述揭示的偏好异质性突出表明,基于消费者偏好做决策时情境至关重要。
  • 中低收入国家证据缺乏令人担忧,这些地区宫颈癌负担最高。
  • 政策制定者需理解驱动个体接种决策的特征并相应调整国家和临床指南,以提高接种率、缩小接种缺口并减少生殖健康服务中的不公平。

研究设计与样本

  • 系统文献综述,检索PubMed和Embase数据库中截至2019年5月的HPV疫苗接种离散选择实验(DCE)。
  • 从164项识别研究中纳入12项符合标准的研究;8项来自高收入国家(HICs),4项来自中低收入国家(LMICs)。
  • 5项研究分别考察接种者偏好、5项考察父母偏好,仅2项评估提供者偏好;研究在人群、属性和方法学上异质性较大。
  • 提取数据制表,并使用两个检查表对纳入研究进行质量评价;所有属性归类为结局、过程或成本属性,采用极差法计算属性的相对重要性。

主要发现

  • 总体上结局指标是最突出的属性,有效性 consistently 获得高相对重要性评分。
  • 接种年龄等过程因素在决策中也起重要作用。
  • 高收入国家与中低收入国家之间的差异在成本属性上最为突出。

临床怎么用

  • 政策制定者应基于本地消费者偏好证据理解驱动接种决策的关键特征,并据此调整国家和临床指南以提高HPV疫苗接种率。
  • 在设计和实施HPV疫苗接种项目时,需同时关注结局属性(如有效性)和过程属性(如接种年龄)对接种决策的影响。

局限性

  • 纳入研究在调查人群、纳入属性和方法学方法上异质性较大。
  • 中低收入国家证据缺乏,而这些地区宫颈癌负担最高。
  • 仅2项研究评估了提供者偏好,提供者视角证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To systematically review, appraise and evaluate available evidence regarding discrete-choice experiments (DCEs) for the human papilloma virus (HPV) vaccination in order to support policymakers in making reasonable and effective vaccination program implementation decisions. METHODS: A systematic literature review was conducted using the databases PubMed and Embase for DCEs in HPV up to May 2019. Extracted data was tabulated and two checklists were used for the quality appraisal of the included studies. All attributes were categorized in outcome, process or costs attributes and the relative importance of attributes was calculated using the range method. RESULTS: Out of 164 identified studies, 12 met the inclusion criteria. Eight were from high income countries (HICs) and four from low and middle-income countries (LMICs). Five studies each examined vaccinee and parent preferences, while only two assessed the providers' preferences. The studies were rather heterogenous in terms of the populations investigated, the attributes included and the methodologic approach. Overall, outcome measures were the most prominent attributes and effectiveness consistently yielded high relative importance scores. But also process factors, such as the age at vaccination, played an important role for decision making. Discrepancies between HICs and LMICs were most prominent for cost attributes. CONCLUSION: The heterogenous preferences this review elicited highlight the importance of context when making decisions grounded on consumer preferences. Especially the lack of evidence from LMICs, where the burden of cervical cancer is highest, is worrisome. In order to increase uptake, close vaccination gaps and reduce current inequities in (reproductive) healthcare, policy makers need to understand the features that drive individual vaccination decisions and adapt national and clinical guidelines accordingly. Future research therefore needs to focus on LMICs in order to elicit preferences of those most vulnerable populations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lack A, Hiligsmann M, Bloem P, et al. Parent, provider and vaccinee preferences for HPV vaccination: A systematic review of discrete choice experiments. Vaccine. 2020. PMID: 33023774. doi:10.1016/j.vaccine.2020.08.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。